Full Press Release Details
DALLAS--(BUSINESS WIRE)--Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026
LTRN Positive Sentiment
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026
Key Takeaway: Lantern Pharma has announced its participation in the ThinkEquity Conference scheduled for October 15th, 2026, in New York City. This event presents an opportunity for the company to showcase its developments and engage with potential investors. The conference is expected to highlight Lantern's ongoing projects and future plans.
Market Sentiment Analysis
POSITIVE FACTORS
- Lantern Pharma is actively participating in industry conferences.
- The presentation at ThinkEquity Conference indicates confidence in their pipeline.
- Engagement in events can attract investor interest.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+20%
120-day peak, hindsight
Typical move
4%
average across 5 past catalysts
Cash runway
~6 mo
High dilution risk
Lead asset
Tavocept in combination with cisplatin and either docetaxel or paclitaxel
Phase 3 · Non-small Cell Lung Cancer
Frequently Asked Questions
When is Lantern Pharma presenting?
Lantern Pharma is scheduled to present on October 15th, 2026.
Where will the presentation take place?
The presentation will take place at the ThinkEquity Conference in New York City.
What is the significance of the conference?
The conference provides an opportunity for Lantern Pharma to engage with investors.
What company is presenting at the conference?
Lantern Pharma is the company presenting at the ThinkEquity Conference.